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Abstract
In the past few years, a plethora of methods for rare variant association with phenotype have been
proposed. These methods aggregate information from multiple rare variants across genomic
region(s), but there is little consensus as to which method is most effective. The weighting scheme
adopted when aggregating information across variants is one of the primary determinants of
effectiveness. Here we present a systematic evaluation of multiple weighting schemes through a
series of simulations intended to mimic large sequencing studies of a quantitative trait. We
evaluate existing phenotype-independent and -dependent methods, as well as weights estimated by
penalized regression approaches including Lasso, Elastic Net and SCAD. We find that the
difference in power between phenotype-dependent schemes is negligible when high quality
functional annotations are available. When functional annotations are unavailable or incomplete,
all methods suffer from power loss; however, the variable selection methods outperform the others
at the cost of increased computational time. Therefore, in the absence of good annotation, we
recommend variable selection methods (which can be viewed as “statistical annotation”) on top
regions implicated by a phenotype independent weighting scheme. Further, once a region is
implicated, variable selection can help to identify potential causal SNPs for biological validation.
These findings are supported by an analysis of a high coverage targeted sequencing study of 1898
individuals.
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Recent studies have shown that rare variants may be important to the underlying etiology of
complex traits [Cohen et al., 2004; Dickson et al., 2010; Gorlov et al., 2008; Haase et al.,
2012; Nelson et al., 2012; Zawistowski et al., 2010] and that they may account for part of
the “missing heritability” [Eichler et al., 2010; Gibson 2010; Maher 2008; Manolio et al.
2009] left by Genome-wide Association Studies (GWAS). Conventional association analysis
methods, which evaluate each variant independently of all others, lack the statistical power
to evaluate rare variants given the sample size of sequencing data currently available.
However, there is increasing evidence that the combined effects of rare variants in the same
exon, gene, region or biological pathway can be used to elucidate complex phenotypes
[Cohen et al., 2004; Nejentsev et al., 2009; Sanna et al., 2011]. Where the effect size of a
single variant may not be large enough to detect with the sample sizes available, a collection
of variants with small effect size, taken together, may be detectable. In order to explore the
potential effects of rare variants in present-day genomic data, a large number of methods
[Bacanu et al., 2011; Cheung et al., 2012; Lee et al., 2012; Li and Leal 2008; Li et al.,
2010a; Madsen and Browning 2009; Mao et al., 2012; Neale et al., 2011; Price et al., 2010;
Tzeng et al., 2011; Wu et al., 2011; Xu et al., 2012; Yi et al., 2011] for aggregating
information across variants have emerged. However there is little consensus on which
method is most effective. The weighting scheme adopted when aggregating across variants
is an important consideration, as is the use of functional or bioinformatics information when
available.
We present an evaluation of multiple weighting schemes through a series of simulations. We
evaluate several existing phenotype-independent [Cohen et al., 2004; Madsen and Browning
2009; Morgenthaler and Thilly 2007] and -dependent weighting schemes [Wu et al., 2011;
Xu et al., 2012], as well as weighting schemes determined by linear regression, penalized
regression and variable selection methods, including Lasso [Tibshirani 1996], Elastic Net
[Zou and Hastie 2005] and SCAD [Xie and Huang 2009]. We conduct simulations under a
variety of scenarios with different numbers of true causal variants, mixtures of direction of
effect and availability of functional information, mimicking sequencing studies of a
quantitative trait. We then apply each of these methods to a set of high coverage targeted
sequencing data [Nelson et al., 2012] of 1898 individuals from the CoLaus population-based
cohort [Firmann et al., 2008].
Materials and Methods
Over the last few years, numerous sensible weighting schemes have been proposed. In most
of these methods a genomic region or variant set is assigned a weighted sum over the
variants meant to describe the burden of potentially influential variants carried by each
individual. We call this weighted sum Si. Further, we assume there are N individuals under
study, indexed by i, and for each individual we have M variants in the region or variant set,
indexed by j.
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First, we examine three approaches that are independent of the observed phenotype. The
first of these is a simple indicator of whether or not rare variants (minor allele frequency,
MAF < 0.01) are present in the region [Cohen et al., 2004]. That is,
where xij is the number of minor alleles observed for individual i at variant j.  is
the estimated MAF of variant j in the data with pseudo counts and Q is the MAF threshold.
In this work, we consider Q=0.05.
Second, we examine a count approach which assigns a higher score to individuals carrying a
larger number of rare alleles [Morgenthaler and Thilly 2007];
with xij being the count of rare alleles for individual i at variant j and q̂j being the estimated
MAF, as defined above.
We also consider the approach proposed by Madsen and Browning [Madsen and Browning
2009] where the weight for variant j is a function of the minor allele frequency (MAF):
with xij and q̂j as above. In the original Madsen and Browning framework for case-control
studies, MAFs are estimated using controls only. However, in this paper, the outcome of
interest is quantitative and we estimate MAF using the entire sample, which makes the
method phenotype-independent in this context.
Phenotype-Dependent Weighting Schemes
We also consider phenotype-dependent regression-based methods. First, we examine the
performance of marginal regression coefficients. That is, we fit the simple linear regression
model Y = xjβ+ε for each variant j separately and independently and then take the fitted
values β̄j to be our weights.
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Though imperfect, this weighting scheme allows investigators to test for associations with
multiple rare variants in cases where N < M and begin to follow up on individual variants
that may potentially be of interest.
Second, we consider weights from ordinary multiple regression, modeling all of the M
variants simultaneously. That is, we fit the model Y = Xβ + ε, where the (i, j)th element of the
matrix X = xij, the minor allele count for individual i at variant j. We then take Si to be as
above, with the fitted values from this multiple regression, βĩ = ξj [Lin and Tang 2011; Xu et
al., 2012].
We also consider weights from several variable selection methods. Such methods are
appealing since we expect the majority of rare variants not to influence the quantitative trait
of interest. Use of penalized regression is therefore expected to reduce the number of non-
zero weights. Similar strategies were recently proposed in the context of rare variant
association testing [Turkmen & Lin, 2012; Zhou, Sehl, Sinsheimer, & Lange, 2010]. In
penalized regression, we solve for the β̃′s which best fit the data, subject to some
constraint(s) or penalty. That is, instead of minimizing the sum of squared error, (Y − βX)′(Y
− βX), we aim to minimize the sum of squared errors and an additional penalty term, (Y −
βX)′(Y − βX) + P(λ, β). In general, the greater the number of parameters included in the
model, the greater the penalty. A number of penalty functions have been proposed and
extensively studied in the recent statistical literature [Heckman and Ramsay 2000;
Hesterberg et al., 2008; Kyung et al., 2010; Wu and Lange 2008]. Of these, we chose three:
the Lasso which imposes a linear penalty [Tibshirani 1996], Elastic Net (EN) which imposes
a quadratic penalty [Zou and Hastie 2005] and SCAD which is designed to penalize smaller
coefficients more heavily than larger coefficients [Xie and Huang 2009].
For Lasso and SCAD, only one tuning parameter, λ, is required. We used the R packages
lars [Efron, Hastie, Johnstone, & Tibshirani, 2004] and ncvreg [Breheny & Huang, 2011]
with default parameter values, which is to choose the optimal λ among a grid of 100 possible
values equally spaced on the log-scale. For Elastic Net, there are two tuning parameters, one
for the linear component and one for the quadratic component. The linear term, λ1, is chosen
in the same way as the λ parameter for the Lasso and SCAD methods, discussed above. The
quadratic parameter, λ2, was set to 1 in all simulations and for the real data. We used the R
package elasticnet to fit the EN models [Zou & Hastie, 2005]. After model fitting, we then
use estimated coefficients from each of these variable selection methods as weights. The
number of non-zero coefficients included is upper-bounded by 100 for each of these
schemes throughout this work.
Under each weighting scheme examined, we determine the significance of a genomic region
using a score test of the following form:
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 in which N is the number of individuals under study, and Yi is the quantitative
trait value for the ith individual. Si is the genetic score for the ith individual, a weighted sum
across multiple variants. Specifically, xij is the number of minor alleles observed for
individual i at variant j where xij are not normalized. M is the number of variants in the
region under study (discovered through sequencing in our context) and ξj is the weight of
variant j under one of the above weighting schemes. The analytical distribution for this
statistic is not generally known in this context, so significance must be assessed empirically
by permutation.
Additionally, we apply the similarity-based method SKAT [Wu et al., 2011] to each of our
simulated data sets and the real data set for comparison. We use weights based on the default
Beta distribution implemented in the SKAT package, version 0.79. We will comment in the
Discussion section on the conceptual differences between the weighting schemes we
consider in this work and the SKAT methodology.
Simulation Setup
We simulate 45,000 chromosomes for a series of 100 50Kb regions with a coalescent model
[Schaffner et al. 2005] that mimics linkage disequilibrium (LD) in real data, accounts for
variations in local recombination rates and models population history consistent with the
CEU samples. We then randomly select 2,000 simulated chromosomes (forming 1,000
diploid individuals) to mimic a large sequencing study. For each region, we simulate one
single pool of 45,000 chromosomes instead of multiple pools of 2,000 chromosomes so that
the causal variants in each region can be determined by population MAFs (MAFs calculated
using the entire population of 45,000 chromosomes) and thus retained across replicates from
the same region. We assume only rare variants (0.001< population MAF <0.05) influence
the value of the quantitative trait and we randomly select m variants that truly influence the
quantitative trait value. For each variant, we independently assign the direction of influence
according to r, the probability that a causal variant will increase the trait value. Following
Wu et al [Wu et al., 2011], we then simulate quantitative traits under the null model:
where E1i, E2i and εi are independent with E1i ∼ Bernoulli(0.5) to mimic a binary covariate,
E2i ∼ Normal(0,1) to mimic a continuous covariate, and εi ∼ Normal(0,1). We also simulate
quantitative traits under an alternative model:
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where βj = rj |k × F(MAFj)| and rj = 1 with probability r and rj = −1 with probability (1-r).
E1i, E2i and εi are as before, j indexes the truly causal variants and  is the number of
minor alleles individual i has at causal variant j. The link function F takes one of the
following forms:
where N is the number of individuals sequenced. We call the first link function log, the
second logit, and the third Madsen-Browning (MB). In addition, we also consider
Frandom(q), a random value chosen from the exponential(1) distribution, independent of q
and multiplied by k. The constant k is a scaling factor to control the magnitude of the change
in quantitative trait due to truly causal genetic variants. In our simulations k is set to 0.2,
which keeps the heritability h2, between 0.1% and 2.5%. Complex human quantitative traits
are thought to have heritability estimates in this range [Manolio et al., 2009]. In the Results
section, we report the results for the logit link function; results for all four link functions are
given in the Supplementary materials.
To assess significance in each simulated setting, score test statistic from each weighting
scheme is compared to the empirical distribution of the test statistic obtained under the null
simulations. We assess the significance of each test at the α=0.01 level using the empirical
null distribution, which we approximate using 100,000 data sets simulated under the null
hypothesis of no variant contributing to the quantitative trait.
Simulation of Data Sets under the Null Hypothesis—For each of the 100 regions
we simulate, we randomly select 100 samples of 2,000 chromosomes (forming 1,000 diploid
individuals). We then assign quantitative trait values under the null model specified above.
Using these 100 × 100=10,000 data sets simulated under the null hypothesis, we obtain the
empirical null distribution of the test statistics for each method.
Simulation of Data Sets under Different Alternative Hypotheses—For each
choice of r, m and F(.), we select 2,000 chromosomes from the population of 45,000
chromosomes again via simple random sampling. Again, we randomly pair these
chromosomes to form diploid individuals and replicate 100 times for each region. For each
replicate, we randomly select m rare variants to be causal. Each causal variant is assigned a
direction in which to exert its effect (positive with probability r and negative with
probability 1 − r).
Simulation of “Good” Functional Annotation—In each simulated data set, we
annotate variants as “functional” or “non-functional”. We assume that we have a reasonably
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good bioinformatics tool such that a true causal variant has 90% probability to be annotated
as “functional”. Even a perfect bioinformatics tool can only predict functionality, not
causality or association with a particular trait of interest. Because of this, we annotate an
additional random number of W non-causal variants as “functional”. Kryukov and
colleagues [Kryukov et al., 2009] have estimated that approximately one third of de novo
missense mutations (that would be predicted as functional by a sensible bioinformatics tool)
have no effect on phenotypic traits. We therefore used 1/3 as the lower bound for the
fraction of non-causal variants annotated and simulated W ∼ N(25,5) , rounded to the
nearest integer. We evaluate the performance of each of these weighting schemes both using
all variants without the help of the bioinformatics tool, and using only the “functional”
variants annotated. Under the null distribution, W variants are selected at random.
Simulation of GWAS Data Sets—We use the same choice of causal variants in each
region as in the simulated sequencing data. Consequently, the direction of association and
true effect size of each of these are unchanged. In order to simulate GWAS SNPs, we select
1000 chromosomes from the total 45,000 to mimic the 1000 Genomes [Abecasis et al.,
2012] sample. The simulated 1000 Genomes sample is used to define LD, based on which
GWAS SNPs are selected. For each region, we choose 75 GWAS SNPs consisting of the
first 70 tagSNPs (SNPs with the highest number of LD buddies where an LD buddy is a
SNP with which the r2 >0.8) and 5 SNPs at random from the remaining set of SNPs,
mimicking the Illumina Omni5 or Affymetrix Axiom high-density SNP genotyping
platforms.
Results
In the Absence of a Bioinformatics Tool
Throughout our simulations, we observe several consistent patterns. First, when we apply
these methods in the absence of a Bioinformatics tool (thus, all variants are included in
analysis), variable selection schemes (most noticeably Lasso and EN) outperform other
methods, including SKAT, in nearly all situations (notable exceptions are discussed below).
For example, under the simulated setting of 10 causal variants, among which we expect to
five increase quantitative trait value, the power is 80.0% and 83.7% for Lasso and EN, and
is 0.4%, 7.3%, 7.6%, 43.2%, 25.3%, 60.5%, 41.3%, and 46.6% for Indicator, Count,
Madsen-Browning, Marginal Regression, Multiple Regression, SCAD, SKAT (all variants),
and SKAT (rare variants only) respectively (Figure 1a). Under the simulated setting of 50
causal variants among which 40 are expected to increase quantitative trait value, power is
100% for both Lasso and EN, and is 0.03%, 0.19%, 0.07%, 99.63%, 100%, 100%, 96.9%,
and 98.5% for Indicator, Count, Madsen-Browning, Marginal Regression, Multiple
Regression, SCAD, SKAT (all variants), and SKAT (rare variants only) respectively (Figure
1b).
In the Presence of a Good Bioinformatics Tool
In the presence of a good bioinformatics tool (as introduced in the Methods section) the
power increases for each of the methods previously discussed. Most notably, the phenotype-
independent methods show a substantial gain in power once the bioinformatics tool is
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applied. For example, under the simulated setting of 10 causal variants, among which five
are expected to increase the quantitative trait value, the power is 99.83% and 99.80% for
Lasso and EN, and is 23.91%, 17.15%, %, 18.85%, 97.87%, 99.73%, 99.76%, 98.49%, and
98.34% for Indicator, Count, Madsen-Browning, Marginal Regression, Multiple Regression,
SCAD, SKAT (all variants), and SKAT (rare variants only) respectively (Figure 2a). Under
the simulated setting of 50 causal variants, among which 40 increase quantitative trait value,
power is 100% for both Lasso and EN, and is 99.38%, 98.89%, 96.51%, 100%, 100%,
100%, 100%, and 100% for Indicator, Count, Madsen-Browning, Marginal Regression,
Multiple Regression, SCAD, SKAT (all variants), and SKAT (rare variants only)
respectively (Figure 2b). Although power increases for all methods, the relative performance
of the methods changes little from that under the absence of a bioinformatics tool.
Effect of m (the Number of Causal Variants) and r (% of Positive Causal Variants)
As the number of true causal variants (m) increases, so does power for all methods. This is
to be expected since adding more causal variants increases the signal-to-noise ratio. When
the number of true causal variants is very small, none of the methods have adequate power.
Interestingly, it is in these situations where m is very small that SKAT manifests its
advantage over other methods examined. As r gets smaller (that is, the probability that a
causal variant will contribute positively to the quantitative trait values gets smaller), the
power of the phenotype-independent methods decreases. For example, the phenotype-
independent methods have close to 0 power when r=0.05; while the phenotype-dependent
methods are relatively unaffected by changing values of r (Figure 1a and Figure 2a). We
also observe a slight dip in power in all of the phenotype-dependent schemes when r=0.5
and no bioinformatics information is used (Figure 1a), which is to be expected since the
signals from different directions are canceling one another. Similar trends are seen in all
simulations with all four link functions (shown in supplementary materials).
Weight Estimation Accuracy for Individual Variants
Table 1 shows the correlation between the true and estimated values of the weights for each
method under the simulation settings in which the number of truly causal variants, m, is 10
and the proportion of variants contributing in the positive direction, r, is 80%. Of note, the
correlation between true and estimated weights increases for all methods with the addition of
bioinformatics filtering. The Elastic Net and Lasso yield the highest correlations between
estimated and true weights, both in situations where we restrict to variants that are likely to
be functional (Pearson correlations of 0.285 and 0.355), and when we do not (Pearson
correlations of 0.744 and 778).
Identification of Individual Causal Variants
When using variable selection schemes, we have the opportunity to identify individual
causal variants within the region or variant set under study. Figure 3 illustrates the accuracy
with which the causal variant(s) can be identified by each weighting scheme. Note that the
causal variant(s) are not always 100% identified, but in many cases, the causal variant, or a
variant in high LD (r2 > 0.8), have estimated non-zero weights. For example, if we fix
m=10, r=0.8 and the logit link function, without considering LD buddies, we need to
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consider the top 696 (109 and 12) variants in order to detect 90% (60%, 30%) of the causal
variants using EN (Figure 3a); taking LD buddies into consideration, the numbers decrease
to 378 (14 and 4) (Figure 3b). When we also consider functional information we consider
fewer variants and narrow the field to include a higher proportion of truly causal variants. In
this case, we need to consider the top 408 (16 and 4) variants in order to detect 90% (60%,
30%) of the causal variants (Figure 3c) without considering LD buddies; with LD buddies
taken into consideration, the numbers decrease to 374 (13 and 3) (Figure 3d).
Results with GWAS Data Sets
Studies that sequence a portion or the entirety of the genome are becoming increasingly
common, but still much more GWAS data exist than sequencing data. Imputation has been
shown to accurately predict genotypes at untyped variants from GWAS data in a variety of
circumstances [Auer et al., 2012; de Bakker et al., 2008; Li et al., 2010a; Li et al., 2009b;
Liu et al., 2012; Marchini and Howie 2010]. Using our simulated GWAS data and simulated
reference, we observe that variable selection can improve power for GWAS data as well.
However, the power is consistently lower than that under the sequencing setting due to the
imperfect rescue of information through imputation (comparing Figure 1 with
Supplementary Figure 3). In our simulations, the imputation accuracy is 99.66% for all
variants and 99.98% for rare variants, but most of the inaccuracies are due to missed rare
variants. In fact, among variants with MAF < 0.001 nearly all inaccuracies are due failure to
identify the minor allele. Specifically, the squared Pearson correlation between the imputed
genotypes (continuous, ranging from 0 to 2) and the true underlying genotypes (coded as 0,
1 and 2) is only 0.2397 for variants with MAF < 0.001. Supplementary Figure 3 shows the
relative power of these weighting schemes over a range of r (Supplementary Figure 3a) and
m (Supplementary Figure 3b).
Results with Real Data Set
Of the over 6,000 individuals in the CoLaus cohort [Firmann et al., 2008], 1,898 had
recorded total cholesterol and targeted sequence data in 202 drug target genes [Nelson et al.,
2012]. Sequencing was done at moderately high coverage (with median coverage 27X) and
genotype calls were obtained using SOAP-SNP [Li et al., 2009a]. Sporadic missing
genotypes were imputed with MaCH [Li et al., 2010b]. One gene previously known to be
associated with total cholesterol in these data is used as a positive control. We test each of
the 172 autosomal genes with and without removing nonfunctional variants using
ANNOVAR [Wang et al., 2010]. For each method, we estimate weights in association with
total cholesterol and, for the methods that accommodate covariates, we adjust for age, age2,
sex and the first five principal components. For the phenotype-independent methods, no
covariate adjustment is performed and significance is assessed by permutation of the Yi's.
For methods allowing covariates (marginal and multiple regression, Lasso, EN and SCAD),
permutation of outcomes alone is not appropriate. For these methods, we fit a regression
model, Yi ∼ Zi, where Z is the matrix of covariates and then obtain residuals, εi. The εi's are
then randomly permuted to obtain a set of ε*i's, the permuted residuals. For each
permutation, we fit the model ε*i ∼ Xi in order to re-estimate the weights ξj and scores Si as
in [Davidson and Hinkley 1997]. We do 10,000 such permutations and, from these, obtain a
null distribution of statistics with which to assess significance. Since SKAT produces
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analytical p-values shown to preserve type I error [Wu et al., 2011], we use the SKAT
analytical p-values without permutation.
When all variants regardless of bioinformatics prediction are included, the variable selection
methods Lasso and EN yield the smallest p-values compared to other methods for the
previously implicated gene. However, the previously implicated gene is not the most
significant among the 172 genes tested. Using ANNOVAR annotations [Wang et al., 2010],
we restrict to non-synonymous variants in coding regions of the genome only. When
considering only these functional variants, most weighting schemes identify the correct gene
with highly significant p-values (Table 2 and Supplementary Figure 4).
Discussion
In summary, through extensive simulation studies with varying number, model, and
direction of causal variant(s) contributing to a quantitative trait, we find that functional
annotations derived from good set of bioinformatics tools can substantially boost power for
rare variant association testing. In the absence of good bioinformatics tools, “statistical”
annotation based on phenotype-dependent weighting of the variants, particularly through
variable selection based methods to both select potentially causal/associated variants and
estimate their effect sizes, manifests advantages. This observation holds for both
sequencing-based studies or studies based on a combination of genotyping, sequencing, and
imputation. We also find supporting evidence from application to a real sequencing-based
data set.
The price one has to pay for adopting phenotype-dependent methods is the necessity of
permutation, which can be easily performed through permuting of residuals for the analysis
of quantitative traits [Davidson and Hinkley 1997; Lin 2005] or using the BiasedUrn method
[Epstein et al., 2012] recently proposed for binary traits. This, in turn, increases
computational costs. Therefore, we recommend primarily using phenotype-dependent
weighting for refining the level of significance. That is, we recommend applying phenotype-
dependent weighting only to genomic regions or variant sets that have strong evidence of
association (but not necessarily reaching genome-wide significance) from methods that do
not require permutation (for example, SKAT [Wu et al., 2011]).
We note that testing over a region by aggregating information across variants is a different
task from estimating effect sizes of individual variant (as measured by the variant weights in
our work). Perfection in the latter (that is, being able to estimate weights for each individual
variants accurately) leads to perfection in the former (that is, maximal testing power over the
region harboring those variants); but not vice versa. Based on our simulations where we
know the true contribution (effect size) of each individual variant, we find that individual
effect sizes cannot be well estimated (Pearson correlation between true and estimated effect
sizes < 0.5 even for the best variable selection based methods). However, these methods can
still increase power of region or variant set association analysis without accurate estimation
of individual variant effect sizes. In addition, these methods are able to identify the vast
majority of the causal variants, particularly when LD buddies are considered.
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In this paper, we mainly consider aggregation of information at the genotype level (where
we first obtain a regional genotype score via a weighted sum of genotype scores for
individual variants and then assess the association between the regional genotype score and
the phenotype of interest), which underlies the largest number of rare variant association
methods published. In contrast, there are methods that aggregate information at the effect
size level (for example, SKAT [Wu et al., 2011] where the final regional score test statistic
is a weighted sum of the test statistics for individual variants) or at the p-value level, for
example in [Cheung et al., 2012]. Our comparisons with SKAT suggest that the same
conclusions apply to aggregation methods at levels other than genotype.
Lastly, although one could potentially argue that the phenotype-dependent methods require
an undesirable computing-power trade-off in the presence of good bioinformatics tools, in
practice, we rarely (if ever) get perfect bioinformatics tools. In addition, even perfect
bioinformatics tools can only predict functionality but NOT causality or association with
particular phenotypic trait(s) of interest. Therefore, we view that the application of
“statistical annotation” through phenotype-dependent weighting, particularly using variable
selection based methods, to top regions or variant sets implicated by computationally
efficient phenotype-independent methods, is valuable.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Power Comparison in the Absence of a Bioinformatics Tool
Figure 1 shows the power (Y-axis) of the different methods across a wide spectrum of m
(the number of true causal variants) and r (the proportion of variants that contribute to our
quantitative trait in a positive direction) in the absence of a bioinformatics tool. In Figure 1a,
we fix m at 10 and show power comparisons across the entire spectrum of r (X-axis). Figure
1b shows how power changes as a function of m (X-axis) with r fixed at 0.8. Here we use
the logit link function.
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Figure 2. Power Comparison in the Presence of the Good Bioinformatics Tool
Figure 2 shows the power (Y-axis) of the different methods across a wide spectrum of m
(the number of true causal variants) and r (the proportion of variants that contribute to our
quantitative trait in a positive direction) in the presence of the good bioinformatics tool
described in the Method section. Like in Figure 1a, we fix m at 10 and show power
comparisons across the entire spectrum of r (X-axis) in Figure 2a. Similarly, Figure 2b how
power of the methods changes as a function of m (X-axis) with r fixed at 0.8. Again the logit
link function is used.
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Figure 3. How Far Down the Ranked List are the Truly Causal Variants when All Variants are
Included?
Figure 3a shows the number of variants that must be considered (Y-axis) in order to catch
the top 10%, 20% … 100% of truly causal variants (X-axis) in simulation when all variants
are considered. We assume that the variants are ranked in order of significance. These plots
aggregate true and estimated weights from all 10,000 replicates of the experiment and once
again, we fix r at 0.8, m at 10 and use the logit link function. Figure 3b. takes LD buddies
(variants with r2 > 0.8 with causal variant) into consideration. Figure 3c. restricts the results
from 3a. to functional variants only using a good bioinformatics tool. Figure 3d. is restricted
to functional variants only and takes LD buddies into account.
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Table 1
Average Pearson Correlation of True and Estimated Weights (m=10 and r=0.8)




Marginal Regression 0.1588 0.6490




SKAT (all) - -
SKAT (rare only) - -
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Table 2
Permuted P-values1 on the Positive Control Gene in the Real Data Set




Marginal Regression 0.166 0.00420




SKAT (all) 0.329 0.00142
SKAT (rare only) 0.348 0.00142
1
Except for SKAT(all) and SKAT(rare only)
***
: Most significant p-value under each column is in bold, italicized and flagged with ***.
**
: Second most significant p-value under each column is in bold and flagged with **.
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